Although multiple studies have suggested the roles of Akt and ERK in promoting drug resistance in a variety of cancer types24–26 through distinct molecular mechanisms, the effects of these kinases on chemotherapy response in Ewing sarcoma have not been described. The gene discussed is AKT1; the disease is Ewing sarcoma.